FTS3‐01‐04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE. (1st July 2019)

Record Type:: Journal Article
Title:: FTS3‐01‐04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE. (1st July 2019)
Main Title:: FTS3‐01‐04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE
Authors:: Henley, David
Sperling, Reisa A.
Aisen, Paul S.
Raman, Rema
Donohue, Michael C.
Ernstrom, Karin
Shi, Yingqi
Karcher, Keith
Raghavan, Nandini
Tymofyeyev, Yevgen
Brashear, Robert
Novak, Gerald P.
Thipphawong, John
Saad, Ziad
Kolb, Hartmuth C.
Romano, Gary
Abstract:
Is Part Of:: Alzheimer's & dementia. Volume 15:Supplement 7S(2019)Part 17
Journal:: Alzheimer's & dementia
Issue:: Volume 15:Supplement 7S(2019)Part 17
Issue Display:: Volume 15, Issue 7, Part 17 (2019)
Year:: 2019
Volume:: 15
Issue:: 7
Part:: 17
Issue Sort Value:: 2019-0015-0007-0017
Page Start:: P873
Page End:: P874
Publication Date:: 2019-07-01
Subjects:: Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83
Journal URLs:: http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.jalz.2019.06.4621 ↗
Languages:: English
ISSNs:: 1552-5260
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13225.xml